AMEX

Hedgeye 130/30 Equity ETF (HELS)

301 Thanks from members

The Hedgeye 130/30 Equity ETF (HELS) faces an unfavorable 6–12 month outlook, weighed down by weak performance relative to long-short peers, a tiny $22.5M AUM, wide bid-ask spreads, and a challenging macroeconomic environment characterized by tariff-driven growth scares.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →